NCT05609331View on ClinicalTrials.gov

Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 17, 2022

Primary Completion Date

January 7, 2026

Study Completion Date

January 7, 2026

Conditions
Lung Cancer
Interventions
OTHER

Simulated Online Adaptive Planning

The results of the MRI-guided radiation therapy will be compared to conventional radiation therapy (guided by CT scans) during this study

RADIATION

Stereotactic MRI-guided adaptive radiotherapy-SMART

The results of the MRI-guided radiation therapy will be compared to conventional radiation therapy (guided by CT scans) during this study

Trial Locations (1)

77030

M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER